PharmD Transitions of Care Program (PHARMD-TOC): A Community Pharmacy Transitions of Care Program

Study Overview
=================
Brief Summary
-----------------
Many hospitals and medical groups have developed transitions of care (TOC) programs or procedures in an attempt to reduce hospital readmission and reutilization rates of patients discharged from the hospital. As healthcare's most accessible practitioners, Community Pharmacists have a unique opportunity to assist with reducing unnecessary hospital re-utilization (re-admissions and emergency department visits) after hospital discharge. The purpose of this study is to conduct and evaluate the implementation of a Community Pharmacy-based Transitions of Care (TOC) Program for high-risk post-discharge patients of PIH Health Hospital-Whittier (PIH). The primary objective will be to compare the proportion of patients with hospital re-utilization (readmission, observation status, ED visits) during 30-days post hospital discharge between patients randomly assigned to the PHARMD-TOC group vs. the historic rate at PIH. Secondary analyses will examine differences between groups and describe implementation details of the PHARMD-TOC model of patient care.

Official Title
-----------------
PharmD Transitions of Care Program (PHARMD-TOC): A Community Pharmacy Transitions of Care Program

Conditions
-----------------
Disease, Chronic

Intervention / Treatment
-----------------
* Other: Usual Care
* Other: PharmD TOC


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: - Admission LACE Score: in moderate range (5 to 9) And Taking high risk medication(s): anticoagulants, insulin, oral antiplatelet agents, oral hypoglycemic agents, opioid analgesics, digoxin Or Taking at least 5 medications AND have one of following: CHF, COPD, Asthma, Pneumonia, Diabetes, ESRD, Schizophrenia, Bi-Polar, Dizziness, History of Falls And Medical or Surgical Unit patients Age > 18 years Being discharged to home (with or without Home Health services) English and/or Spanish speaking Will have access to a telephone post-discharge Ability to give consent Patient admitted to hospital through the emergency department, as a direct admission or as a transfer, or as an elective surgery patient Exclusion Criteria: - Patients with observation status Caremore Health Plan patients (Caremore has a separate post-discharge program) Patients discharged and followed up by the PIH Coumadin Clinic Patients discharged to Residential MD House Calls program Patients discharged to Skilled Nursing Facility Anyone with planned readmissions Obstetrics patients Hospice patients Oncology patients Anyone who does not meet provisions of protocol Anyone unwilling or unable to give consent for study procedures and data access

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: PHARMD-TOC i<br>PharmD Follow-Up Post Discharge | Other: PharmD TOC<br>* patients participating in a community pharmacy-based Transitions of Care Program (PHARMD-TOC)<br>|
| Active Comparator: USUAL CARE<br>Usual Post Discharge Procedures | Other: Usual Care<br>* patients participating Usual Care discharge services<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Proportion Patients with Hospital Reutilization | proportion of patients with hospital re-utilization (readmission, observation status, ED visits) during 30-days post hospital discharge | 30 days post hospital discharge |